Home > Insider Trading > Filing (0000919574-15-007187)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1327467	Celator Pharmaceuticals Inc	CPXX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1576115	Valence Life Sciences Gp Ii Llc	C/O Valence Life Sciences Llc 590 Madison Avenue, 21St Floor New York NY 10022	No	No	No	Yes
1576244	W Eric Roberts	C/O Valence Life Sciences Llc 590 Madison Avenue, 21St Floor New York NY 10022	No	No	No	Yes
1600038	Valence Cdk Spv, L.p.	C/O Valence Life Sciences Llc 590 Madison Avenue, 21St Floor New York NY 10022	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-09-30	200	$1.67	159,986	No	4	P	Direct
Common Stock	Acquisiton	2015-09-30	5,000	$1.62	164,986	No	4	P	Direct
Common Stock	Acquisiton	2015-09-30	2,000	$1.68	166,986	No	4	P	Direct
Common Stock	Acquisiton	2015-09-30	3,000	$1.66	169,986	No	4	P	Direct
Common Stock	Acquisiton	2015-10-01	2,000	$1.64	171,986	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,123,612	Indirect	See Footnote

Footnotes

The reported securities are directly owned by Valence CDK SPV, L.P. ("CDK SPV"). Valence Life Sciences GP II, LLC ("GP II") is the sole general partner of CDK SPV. In his capacity as the sole manager of GP II, Eric Roberts shares voting and investment authority over the securities held by CDK SPV. GP II and Mr. Roberts may be deemed to beneficially own the securities held by CDK SPV. Mr. Roberts and GP II disclaim beneficial ownership of these securities except to the extent of their respective pecuniary interests therein.